Chronos and Aptuit partner up for addictive behaviour programmes
The companies will work together on integrated drug discovery -…
The companies will work together on integrated drug discovery - medicinal and computational chemistry, biology and DMPK - to optimise Chronos’ selective orexin 1 antagonists that have shown promise in treating addiction.